PLYX - Polaryx Therapeutics, Inc. Common Stock
NEXT EARNINGS:
Jun 3, 2026
EPS Est: $-0.03
Price:
--
--
Market Cap:
393.04M
Volume:
2,591,764
Avg Volume:
3,052,458
52 Week Range:
2.2-48.91
Sector:
Healthcare
Industry:
Biotechnology
Beta:
N/A
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
11
IPO Date:
2026-02-02
EPS (TTM):
-0.07
P/E Ratio:
-218.34
Revenue (TTM):
N/A
Total Assets:
5.42M
Total Debt:
N/A
Cash & Equiv:
5.14M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-162.4%
Debt/Equity:
N/A
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-25 | $-0.02 | $-0.03 | +33.3% | — | — | — |
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Net Income | (8.98M) | (30.36M) | (3.78M) |
| EPS | -0.19 | -0.16 | -0.02 |
| Total Assets | 5.42M | 5.00M | 2.31M |
| Total Debt | 0 | 0 | 128,000 |
| Cash & Equivalents | 5.14M | 4.62M | 2,000 |
| Operating Cash Flow | (3.94M) | (2.57M) | (173,000) |
| Free Cash Flow | (3.94M) | (2.57M) | (173,000) |
| FCF per Share | -0.08 | -0.01 | -0.00 |
| Book Value | 4.57M | 4.71M | 1.28M |
| Cash & ST Investments | 5.14M | 4.62M | 2,000 |
| ROC Equity | -1.97 | -6.44 | -2.96 |